Inventor
KATADA HITOSHI
JP17 patents
⚠️ This page may combine multiple inventors who share the name “KATADA HITOSHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHUGAI PHARMACEUTICAL CO LTD
15 patentsUS10919953B2Feb 16, 2021
FcgammaRIIB-specific Fc region variant
CHUGAI PHARMACEUTICAL CO LTD24 citations93
US10738111B2Aug 11, 2020
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
CHUGAI PHARMACEUTICAL CO LTD17 citations93
US10000560B2Jun 19, 2018
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
CHUGAI PHARMACEUTICAL CO LTD26 citations93
US11718678B2Aug 8, 2023
Method for altering plasma retention and immunogenicity of antigen-binding molecule
CHUGAI PHARMACEUTICAL CO LTD7 citations85
US11267868B2Mar 8, 2022
Fc region variant
CHUGAI PHARMACEUTICAL CO LTD13 citations85
US11142587B2Oct 12, 2021
Method for producing polypeptide hetero-oligomer
CHUGAI PHARMACEUTICAL CO LTD13 citations85
US11124576B2Sep 21, 2021
Method for producing polypeptide heteromultimer
CHUGAI PHARMACEUTICAL CO LTD20 citations85
US10766960B2Sep 8, 2020
Heterodimerized polypeptide
CHUGAI PHARMACEUTICAL CO LTD13 citations85
US11454633B2Sep 27, 2022
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
CHUGAI PHARMACEUTICAL CO LTD4 citations83
US12371511B2Jul 29, 2025
Heterodimerized polypeptide
CHUGAI PHARMACEUTICAL CO LTD1 citations63
US12359001B2Jul 15, 2025
Method for producing polypeptide hetero-oligomer
CHUGAI PHARMACEUTICAL CO LTD0 citations62
US12169205B2Dec 17, 2024
Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
CHUGAI PHARMACEUTICAL CO LTD0 citations61
US12448451B2Oct 21, 2025
Anti-CTLA-4 antibody and use thereof
CHUGAI PHARMACEUTICAL CO LTD0 citations59
US12415857B2Sep 16, 2025
Anti-CTLA-4 antibody and use thereof
CHUGAI PHARMACEUTICAL CO LTD0 citations58
US12054544B2Aug 6, 2024
Compositions comprising antigen-binding molecules
CHUGAI PHARMACEUTICAL CO LTD1 citations58